Oxyphenbutazone

This page shows anti-doping rule violation data we have registered for Oxyphenbutazone.

Number of cases in Oxyphenbutazone Last 10 Years

Oxyphenbutazone

Oxyphenbutazone ranks #87 globally among prohibited substances, with 27 registered cases (0.2% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,670 verified cases. Hungary leads with 3 cases, while Equestrian is the most affected sport (23 cases).

Cases of Oxyphenbutazone by Sport
Equestrian
23
Horse racing
4
Top Sport: Equestrian

23

Equestrian cases

0%

Of all violations

27

Total Oxyphenbutazone cases
Equestrian's share of Oxyphenbutazone violations 0%
23 of 27

Equestrian has the most recorded cases of Oxyphenbutazone violations globally, with 23 registered cases — 0% of all 27 verified cases.

Cases of Oxyphenbutazone by Country
Hungary
3
Belgium
3
Italy
3
United Kingdom
3
Saudi Arabia
3
Top Country: Hungary

3

Hungary cases

11.1%

Of all violations

27

Total Oxyphenbutazone cases
Hungary's share of Oxyphenbutazone violations 11.1%
3 of 27

Hungary leads in Oxyphenbutazone violations globally, with 3 registered cases — 11.1% of all 27 verified cases.

Global Substance Ranking

Oxyphenbutazone ranks #87 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,359
#2 Methandienone
833
#3 Norandrosterone
778
#4 Testosterone
758
···
#87 Oxyphenbutazone
27
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 70.4%
19 cases
Female 29.6%
8 cases
Analysis: shows an unusually high proportion of female cases (29.6%) compared to the global average (19.8%), a difference of 9.8 percentage points. Global average: 80.2% male, 19.8% female
Average Suspension Length
6.6
months
Oxyphenbutazone
30.1
months
Global average

The average suspension for Oxyphenbutazone violations is 6.6 months, shorter than the global average of 30.1 months.

This NSAID was mentioned in WADA-related documentation from 2004.

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,670 verified anti-doping rule violations across all sports and all countries, and is updated regularly.